• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HOYA SURGICAL OPTICS, INC. B3PC; INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HOYA SURGICAL OPTICS, INC. B3PC; INTRAOCULAR LENS Back to Search Results
Model Number B3PC (+21.00 D)
Medical Device Problem Code Material Split, Cut or Torn (4008)
Health Effect - Clinical Code Failure of Implant (1924)
Date of Event 04/17/2023
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
This initial emdr is being submitted to fda as a reportable event that occurred in the usa.Note: delayed emdr submission was due to fda esg webtrader account system software issues, per fda esg help desk ticket # (b)(4) (and subsequent ticket # (b)(4).Hoya due diligence is documented under internal (b)(4).Haptic damage is indicated as a potential malfunction related to the iol, as covered under the warnings section of the product's instructions for use (ifu).Regarding section h6 - manufacturer's codes for: type of investigation, findings, and conclusion are pending device return and completion of product investigation.Once the product investigation is completed, a follow-up report will be submitted to fda which will include the manufacturer's codes for type of investigation, findings, and conclusion.
 
Event or Problem Description
Damaged haptic after implantation.Trailing haptic broke during lens insertion.Lens was already in the eye and had to be removed.A second lens was then used with no issues.No incision enlargement, suture, or vitrectomy required.Patient health not impacted; patient has recovered and is fine.
 
Event or Problem Description
Damaged haptic after implantation trailing haptic broke during lens insertion.Lens was already in the eye and had to be removed.A second lens was then used with no issues.No incision enlargement, suture, or vitrectomy required.Patient health not impacted; patient has recovered and is fine.
 
Additional Manufacturer Narrative
This follow-up #1 emdr is being submitted to fda for a reportable event that occurred inside of the usa.The report includes additional information not available/included in the initial report.Additional information: g6 - type of report - noted as follow-up #1 h2 - type of follow-up - noted for corrected information and additional information h6 - added codes for manufacturer's investigation: type; findings; and conclusion.The product was not returned to the manufacturer.The investigation was conducted, with the methods and results as noted below.No abnormalities were found in production and inspection records of the product.(serial no.: (b)(6); model: b3pc).We also confirmed there were not any abnormalities on the loop pull strength test record of the material lot.(sovf-60-03).The exact root cause of the event was not determined.However, based on available information, we believe this event was not caused by our product quality.A review of the most recent complaint trending data indicates that no significant trends have been identified at this time and no capa is required as part of the product evaluation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
B3PC
Common Device Name
INTRAOCULAR LENS
Manufacturer (Section D)
HOYA SURGICAL OPTICS, INC.
110 progress
suite 175
irvine CA 92618
Manufacturer (Section G)
HOYA MEDICAL SINGAPORE PTE LTD
455a jalan ahmad ibrahim
singapore, singapore 63993 9
SN   639939
Manufacturer Contact
goutham pendyala
110 progress
suite 175
irvine, CA 92618
9093896317
MDR Report Key17080626
Report Number3006723646-2023-00065
Device Sequence Number2249993
Product Code HQL
UDI-Device Identifier00886158015789
UDI-Public00886158015789
Combination Product (Y/N)N
Initial Reporter StateTN
Initial Reporter CountryUS
PMA/510(K) Number
P080004
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2023
Device Explanted Year2023
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Company Representative,Distributor
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 06/06/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date09/30/2025
Device Model NumberB3PC (+21.00 D)
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/18/2023
Supplement Date Received by Manufacturer04/18/2023
Initial Report FDA Received Date06/07/2023
Supplement Report FDA Received Date06/29/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured09/30/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-